The information on this website is intended to provide scientific information about Alkermes products and areas of therapeutic interest. Information may include data on investigational uses of approved or unapproved drugs for which safety and effectiveness have not been established. There is no guarantee that such uses will receive health authority approval and Alkermes does not recommend or suggest use of its medicines in a manner inconsistent with approved labeling.
This section includes selected Alkermes abstracts, posters or oral presentations, which have been accepted for congress presentations in the last 2 years. The content contained in this section is subject to congress copyright permissions.
Michael J. Thorpy, MD1; Emmanuel Mignot, MD, PhD2; Bruce C. Corser, MD3; Laura B. Herpel, MD4,5; Luis E. Ortiz, MD6; Jacqueline Brooks, MBBCh, MRCPsych7; Yves Dauvilliers, MD, PhD8
1Albert Einstein College of Medicine, New York, NY, USA; 2Center for Narcolepsy, Stanford University, Palo Alto, CA, USA; 3Sleep Management Institute, Cincinnati, OH, USA; 4Bogan Sleep Consultants, Columbia, SC, USA; 5Medical University of South Carolina, Charleston, SC, USA; 6Johns Hopkins Medical Institutions, Johns Hopkins All Children’s Hospital, St. Petersburg, FL, USA; 7Alkermes, Inc., Waltham, MA, USA; 8Sleep-Wake Disorders Center, Department of Neurology, Gui-de-Chauliac Hospital, Institute for Neurosciences of Montpellier INM, INSERM, University of Montpellier, Montpellier, France
